Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1997 1
2000 1
2002 1
2004 1
2006 1
2009 1
2010 3
2011 1
2012 1
2016 1
2017 1
2018 6
2019 2
2020 2
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR. Taplitz RA, et al. J Clin Oncol. 2018 May 10;36(14):1443-1453. doi: 10.1200/JCO.2017.77.6211. Epub 2018 Feb 20. J Clin Oncol. 2018. PMID: 29461916
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent.
On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM. On S, et al. Among authors: taplitz ra. Br J Haematol. 2022 Apr;197(1):63-70. doi: 10.1111/bjh.18051. Epub 2022 Feb 16. Br J Haematol. 2022. PMID: 35174480
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial.
Chiuppesi F, Zaia JA, Frankel PH, Stan R, Drake J, Williams B, Acosta AM, Francis K, Taplitz RA, Dickter JK, Dadwal S, Puing AG, Nanayakkara DD, Ash P, Cui Y, Contreras H, La Rosa C, Tiemann K, Park Y, Medina J, Iniguez A, Zhou Q, Karpinski V, Johnson D, Faircloth K, Kaltcheva T, Nguyen J, Kha M, Nguyen VH, Francisco SO, Grifoni A, Wong A, Sette A, Wussow F, Diamond DJ. Chiuppesi F, et al. Among authors: taplitz ra. Lancet Microbe. 2022 Apr;3(4):e252-e264. doi: 10.1016/S2666-5247(22)00027-1. Epub 2022 Mar 9. Lancet Microbe. 2022. PMID: 35287430 Free PMC article. Clinical Trial.
Reply to J.A. Talcott.
Taplitz RA, Kennedy EB, Flowers CR. Taplitz RA, et al. J Clin Oncol. 2018 Sep 4:JCO2018793141. doi: 10.1200/JCO.2018.79.3141. Online ahead of print. J Clin Oncol. 2018. PMID: 30179568 No abstract available.
Reply to M.A. Slavin et al.
Taplitz RA, Kennedy EB, Flowers CR. Taplitz RA, et al. J Clin Oncol. 2019 May 1;37(13):1140-1141. doi: 10.1200/JCO.18.02227. Epub 2019 Mar 7. J Clin Oncol. 2019. PMID: 30844317 No abstract available.
27 results